Tryptophan decarboxylation: A quantitatively significant route of tryptophan metabolism  by David, Jean-Claude
Volume 55, number 1 FEBS LETTERS July 1975 
TRYPTOPHAN DECARBOXYLATION:  A QUANTITAT IVELY  S IGNIF ICANT ROUTE OF 
TRYPTOPHAN METABOLISM 
Jean-Claude DAVID 
lnstitut de Biologie Moleculaire, Facultd des Sciences, Place Jussieu, Paris Ve, France 
Received 11 March 1975 
1. Introduction 
We have previously presented findings which indi. 
cated that decarboxylation f the aromatic amino 
acids becomes a major pathway for their metabolism 
when their tissue levels are raised [1,2]. This conclu- 
sion was based in part on the finding that the plasma 
levels attained following oral administration of large 
amounts of one of these amino acids could be further 
elevated (over two-fold) by administrating an aromatic- 
I_,amino acid decarboxylase inhibitor [1 ]. Subsequently 
more direct and quantitative studies were reported on 
the contribution of decarboxylation to the metabolism 
of tyrosine [2]. It was shown that in mice the propor- 
tion of tyrosine metabolized via decarboxylation 
increased up to 42% of the dietary intake with increas- 
ing intake of the amino acid. At higher levels of intake 
decarboxylation was quantitatively more significant 
than transamination. The present experiments were 
designed to obtain a quantitative measure of the role 
of decarboxylation in the metabolism of tryptophan. 
2. Materials and methods 
Male MF1 mice (25-30 g), obtained from Marland 
Farms, Wayne, New Jersey, were used in these studies. 
To minimized the possible ffects of gastrointestinal 
flora on the metabolism of orally administered tryp- 
tophan, the mice were deprived of food and 2 g/1 of 
neomycin sulfate was placed in the drinking water 
24 hr prior to the initiation of all experiments [3]. 
In addition the mice were given 2 mg/kg of sulfasuxi- 
dine by mouth 24 hr and immediately prior to the 
initiation of all experiments. 
RO4-4602 [Ni-D-seryl)-N2-(2,3,4 dihydroxybenzyl- 
hydrozine)] was a gift of Hoffmann-LaRoche, Ltd. 
Nutley, New Jersey. Carboxyl labeled L-tryptophan 
(10 Ci/mol) were obtained from New England Nuclear. 
Results were corrected for quenching by means of an 
infernal standard and are expressed in dpm. 
Mice were given carboxy1-14 C-labeled L-tryptophan 
orally in the presence of varying amounts of non- 
radioactive tryptophan and immediately placed in 
separate 500 ml Erlenmeyer flasks and the expired 
air was continuously passed through two consecutive 
flasks each containing 100 ml of 10 N NaOH to trap 
the CO2. Six hr following the administration f the 
carboxyl labeled tryptophan, the radioactivity in each 
trap was determined by liquid scintillation counting. 
3. Results 
The efficiency and the capacity of the collecting 
system for CO2, was determined asfollows. Five con- 
trol mice were placed in the collecting system and the 
expired air was passed through the sodium hydroxide 
solutions. After six hr, the mice were removed from the 
Erlenmeyer flask and a known amount of Na2 [14C] 03 
was added in their place and the system resealed. Five 
ml of concentrated sulfuric acid was then introduced 
into the flask and the 14CO2 was collected for 30 rain. 
It was found that 97% of the radioactivity originally 
added to the flask could be trapped in the sodium 
hydroxide solution. These results indicated that the 
system used was sufficient o collect all the CO2 
expired by the mice during the six hr period. 
The amount of radioactive CO2 collected from the 
experimental mice, increased with increasing amounts 
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Fig.1. Expired ~4CO2 following administration f carboxyl 
labeled tryptophan as a function of the tryptophan i take. 
Mice were given the decarbozylase inhibitor, Ro 4-4602, 
(50 mg/kg/i.p.), the indicated amounts of non-radioactive 
tryptophan (p.o.), and 10.2 × 106 dpm of carboxyl-labeled 
tryptophan. Expired 14CO~ was collected in sodium hydroxide 
as described in the text. Five mice were used for the deter- 
mination of each point. Results are expressed as dpm of expired 
CO 2 per mouse per 6 hr ± S.E.M. (z~) Significantly different 
from Ro 4-4602 treated animals (p <0.01). (-) Significantly 
different from Ro 4-4602 treated animals (p <0.005). 
(*) Significantly different from Ro 4-4602 treated animals 
(p <0.001). 
the gastro-intestinal tract, plus any voided urine was 
homogenized in 3 vol of water and treated as previous- 
ly described [2]. Tryptamine was isolated from the 
trichloroacetic-acid-soluble fraction by several chromato- 
graphic steps on IRC 50 resin. The trichloroacetic 
acid extract was passed through a 1 × 5 cm column 
previously adjusted to pH 6.5 and the effluent dis- 
carded. The column was washed with 5 ml of water 
followed by 5 ml of 0.5 M phosphate buffer pH 6.5 
and the washings and eluates were discarded. The 
basic fraction was then eluted with 5 ml of 4 N 
ammonia. Authentic tryptamine was eluted in the 
final basic fraction with a recovery varying between 
85 and 90%. 
Shown in table 1 are the amounts of radioactivity 
found in the basic fraction six hr following the admini- 
stration of 3-[14C] tryptophan. As the oral dose of 
tryptophan was increased from the tracer amount to 
0.5, 1.0 and 1.5 g/kg, the radioactivity found in the 
tryptamine-associated fraction increased from 10.8%, 
to 16.8%, 30.5% and 43% of the administered trypt- 
ophan radioactivity. 
These data are in excellent agreement with those 
found on evolved 14CO2 (fig.l). Thus, administration 
of the decarboxylase inhibitor essentially prevented 
of administered tryptophan (see fig. 1). When only 
tracer amounts of carboxyl labeled tryptophan was 
administered approximately 8% of the radioactivity 
was collected as expired CO2. As the dose was pro- 
gressively increased from 0.5 to 1.0 to 1.5 g/kg, this 
increased to 16.3, 30.5 and 42% respectively. As is 
also shown in Fig. 1, when the decarboxylase inhibi- 
tor, Ro 4-4602,  was given the appearance of 14 CO2 
in the expired air was markedly diminished. These 
findings are consistent with the interpretation that the 
14 CO2 originates through the decarboxylation f 
tryptophan. 
Another group of mice were given 3-[14C] trypto- 
phan so that the newly synthesized tryptamine formed 
through decarboxylation would retain the 14C-radio- 
activity. These mice were pretreated with the mono- 
amine oxidase inhibitor pargyline (50 mg/kg i.p.) 24 hr 
and 1 hr prior to the initiation of the experiment. This 
compound was given to prevent further metabolism 
of tryptamine by oxidative deaminations. Six hours 
following the administration of 3-[14 C] tryptophan, 
the animals were killed and the entire carcass, minus 
Table 1 
Extent of decarboxylation as a function of increasing 
tryptopban i take 
Dose of 
tryptophan 
(g/kg) 
dpm × 106/mouse ± S.E.M. 
NaC1 0.9% Ro 4-4602 
Tracer a 1.088 +_ 0.08 0.109 ± 0.012 
0.5 1.504 ± 0.10 0.127 ± 0.008 
1.0 2.720 ± 0.18 0.126 ± 0.005 
1.5 3.835 ± 0.12 0.186 -+ 0.004 
Mice were given orally 10.5 × 106 dpm of 3-[J4C] tryptophan 
in 0.3 ml of distilled water in the presence or absence of three 
different amounts of non-radioactive tryptophan (0.5, 1.0, 1.5 
g/kg) and divided in two groups, At the same time the first group 
received NaCI (0.9% i.p.) and the second group the decarboxylase 
inhibitor, Ro 4-4602 (50 mg/kg i.p.). The animals were killed 
six hr later and the radioactivity in the basic fraction determined 
as described in the test. Four animals were used for the deter- 
mination of each point. 
a The radioactive tracer amount of tryptophan was equivalent to 
5.5-10 -s g/kg. 
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the appearance of radioactivity in the basic fraction, 
a result consistent with the formation of tryptamine 
via the decarboxylation pathway. 
Some of the radioactivity found as CO2 or eluted 
in the basic fraction from the IRC column could have 
arisen by decarboxylation f 5-hydroxtryptophan 
formed from tryptophan. To investigate this trypt- 
amine and 5-hydroxytryptamine were separated by 
paper chromatography (Whatman 3 MM butanol-ace- 
tic acid-water 6:1.5:2.5 v/v/v). It was found that at 
a dose of 1.5 g/kg of tryptophan, 90% of the radio- 
activity in the basic fraction migrated with trypt- 
amine, and 10% with 5-hydroxytryptamine. At a dose 
of 1 g/kg, only 5% were associated with 5-hydroxy- 
tryptamine. At the tracer and 0.5 g/kg doses, all the 
radioactivity was associated with tryptamine. 
we have previously reported for tyrosine [1,2]. Since 
phenylalanine is an excellent substrate of aromatic- 
L-amino acid decarboxylase it is likely that decarboxy- 
lation is also an important route for its metabolism. 
The amines corresponding to the aromatic amino 
acids possess appreciable activity on nerve and smooth 
muscle. However, most of the decarboxylation takes 
place in liver and kidney which are rich in monoamine 
oxidase. Apparently this enzyme is capable of inactivat- 
ing the bulk of the generated amines. Nevertheless, 
one wonders whether or not these large amounts of 
tyramine, tryptamine and phenylethylamine which are 
formed play a physiological role. Even if that were so, 
one must consider the possibility of amine involve- 
ment in some pathologic states. 
4. Discussion 
It has been know for nearly 40 years that trypt- 
ophan can be converted to kynurenine through the 
tryptophan pyrrolase (EC 1.l 3,11.11) pathway [4]. 
This pathway has been considered to be quantitatively 
the most important metabolic route for this amino 
acid [5-7]. Recently, Hayaishi et al. [8] have 
described an indoleamine 2,3-dioxygenase which 
utilizes tryptophan as a substrate and is believed to be 
of some importance in the intestinal wall and brain 
[8,9]. The formation of tryptamine has been considered 
to be a minor route of tryptophan metabolism. We 
have shown in this report that the decarboxylation 
pathway for tryptophan is by no means a minor route 
either during fasting or during high tryptophan i take. 
These findings with tryptophan are similar to those 
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